-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Bellicum Pharmaceuticals, Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2016 to Q1 2023.
- Bellicum Pharmaceuticals, Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $3K, a 40% decline year-over-year.
- Bellicum Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2022 was $11K, a 89.5% decline from 2021.
- Bellicum Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2021 was $105K, a 92.9% decline from 2020.
- Bellicum Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2020 was $1.47M, a 79.5% decline from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)